Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.470
+0.030 (2.08%)
Feb 21, 2025, 4:00 PM EST - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $98.82 million as of February 21, 2025. Its market cap has increased by 35.24% in one year.
Market Cap
98.82M
Enterprise Value
-119.05M
1-Year Change
35.24%
Ranking
Category
Stock Price
1.47
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $98.82M, a decrease of -75.49%. That is a compound annual growth rate of -32.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 98.82M | -18.33% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |